Global Internal Neuromodulation Devices Market By Product (Spinal Cord Stimulator, Deep Brain Stimulator, Vagus Nerve Stimulator, Sacral Nerve Stimulator, Gastric Nerve Stimulator), Lead Type (Percutaneous, Paddle Lead), Indication (Failed Back Surgery Syndrome, Parkinson’s disease, Urinary Incontinence, Epilepsy, Gastroparesis), Battery Type (Primary, Rechargeable), End-User (Hospitals, Clinics, Home Healthcare, Community Healthcare), Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America) – Industry Trends & Forecast to 2026
Market Analysis: Global Internal Neuromodulation Devices Market
Global internal neuromodulation devices market is estimated to reachUSD 15.41 billion by 2026, registering a healthy CAGR of 14.1% in the forecast period of 2019-2026. Rising prevalence of neurological disorders, strong product line and expanded target application to spur market growth.
Market Definition: Global Internal Neuromodulation Devices Market
Internal neuromodulation devices directly bear upon nerves. It’s the technology known for alteration of nerve activity on to a spot by causing electrical or pharmaceutical agents on to a spot. The neuromodulation devices will treat nearly each illness considering each space of body. The diseases or symptoms from headache to neural structure harm to tremor and lots of others. Neuromodulation technology is considerably rising in biotechnology with its broad therapeutic scope.
Due to the vast size of the potential treatment population, as seen, there are 40-50 million patients worldwide of Epilepsy, 26 million in the U.S of Migraine, Spinal cord injuries: 250,000 in the U.S., Parkinson disease: 1.5 million in the U.S., Urinary incontinence: 13 million adults in the U.S. To date, neuromodulation is just beginning to be routinely applied as a therapy for appropriately selected patients in these groups. This significant number is expected to act as a driver to the market growth.
- Rise within the variety of headache and brain disease patients and increase of neurostimulators within the treatment of depression and sleep apnea
- Strong product pipeline to propel the market
- Expanded target applications and new indications are expected to stimulate the growth of neuromodulation
- Unfavorable reimbursement scenario hinders market growth
- Lack of trained professionals likely to hamper market growth
Segmentation: Global Internal Neuromodulation Devices Market
- Spinal Cord Stimulator
- Deep Brain Stimulator
- Vagus Nerve Stimulator
- Sacral Nerve Stimulator
- Gastric Nerve Stimulator
By Lead Type
- Paddle Lead
- Failed Back Surgery Syndrome
- Parkinson’s disease
- Urinary Incontinence
By Battery Type
- Home Healthcare
- Community Healthcare
- North America
- South America
- Rest of South America
- United Kingdom
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Middle East and Africa
- South Africa
- Saudi Arabia
- United Arab Emirates
- Rest of Middle East and Africa
Key Developments in the Market:
- In April 2019, The International Neuromodulation Society and Neuromodulation Society of Australia and New Zealand are presenting a free public event, about neurostimulation for chronic conditions such as chronic pain, overactive bladder, and Parkinson's disease
- In March 2019, The Company Innovative Neurological Devices announced FDA approval of its wearable cranial electrotherapy stimulator for treatment of anxiety, depression and insomnia
Competitive Analysis: Global Internal Neuromodulation Devices Market
Global internal neuromodulation devices market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of internal neuromodulation devices market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Key Market Competitors: Global Internal Neuromodulation Devices Market
Few of the major competitors currently working in the internal neuromodulation devices market are Medtronic, Boston Scientific Corporation, Abbott, Nevro Corp, Cyberonics, Inc., Neuros Medical., Inspire Medical Systems Inc., StimGuard LLC, SPR Therapeutics, ALEVA NEUROTHERAPEUTICS SA, BioControl Medical, Bioness Inc.. ReShape Lifesciences, Inc. LivaNova PLC, NeuroPace, Inc. Synapse Biomedical Inc. Soterix Medical Inc, Accellent, DynaMD, StimGuard LLC, and others
Research Methodology: Global Internal Neuromodulation Devices Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or can drop down your inquiry.
The key research methodology used by DBMR Research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Reasons to Purchase this Report
- Current and future of global internal neuromodulation devices market outlook in the developed and emerging markets
- The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
- Regions/Countries that are expected to witness the fastest growth rates during the forecast period
- The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
- All segmentation provided above in this report is represented at country level
- All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)